Search

Author/Creator Stascheit, Frauke

2. Complement activation profiles in anti‐acetylcholine receptor positive myasthenia gravis. (24th February 2023)

Authors:
Stascheit, Frauke; Chuquisana, Omar; Keller, Christian W.; Ambrose, Philip Alexander; Hoffmann, Sarah; Gross, Catharina C.; Lehnerer, Sophie; Wiendl, Heinz; Willcox, Nick; Meisel, Andreas; Lünemann, Jan D.
Journal:
European journal of neurology
Issue:
Volume 30:Number 5(2023)
Page Start:
1409
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Eculizumab versus rituximab in generalised myasthenia gravis. Issue 5 (4th March 2022)

Authors:
Nelke, Christopher; Schroeter, Christina B; Stascheit, Frauke; Pawlitzki, Marc; Regner-Nelke, Liesa; Huntemann, Niklas; Arat, Ercan; Öztürk, Menekse; Melzer, Nico; Mergenthaler, Philipp; Gassa, Asmae; Stetefeld, Henning; Schroeter, Michael; Berger, Benjamin; Totzeck, Andreas; Hagenacker, Tim; Sch...
Journal:
Journal of neurology, neurosurgery and psychiatry
Issue:
Volume 93:Issue 5(2022)
Page Start:
548
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Prediction of the generalization of myasthenia gravis with purely ocular symptoms at onset: a multivariable model development and validation. (June 2022)

Authors:
Li, Feng; Zhang, Hongbin; Tao, Ya; Stascheit, Frauke; Han, Jiaojiao; Gao, Feng; Liu, Hongbo; Carmona-Bayonas, Alberto; Li, Zhongmin; Rueckert, Jens-C.; Meisel, Andreas; Zhao, Song
Journal:
Therapeutic advances in neurological disorders
Issue:
Volume 15(2022)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Safety, efficacy, and tolerability of efgartigimod in patients with generalised myasthenia gravis (ADAPT): a multicentre, randomised, placebo-controlled, phase 3 trial. Issue 7 (July 2021)

Authors:
Howard, James F; Bril, Vera; Vu, Tuan; Karam, Chafic; Peric, Stojan; Margania, Temur; Murai, Hiroyuki; Bilinska, Malgorzata; Shakarishvili, Roman; Smilowski, Marek; Guglietta, Antonio; Ulrichts, Peter; Vangeneugden, Tony; Utsugisawa, Kimiaki; Verschuuren, Jan; Mantegazza, Renato; De Bleeker, Jan;...
Journal:
Lancet neurology
Issue:
Volume 20:Issue 7(2021)
Page Start:
526
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. Safety, efficacy, and tolerability of efgartigimod in patients with generalised myasthenia gravis (ADAPT): a multicentre, randomised, placebo-controlled, phase 3 trial. Issue 7 (July 2021)

Authors:
Howard, James F; Bril, Vera; Vu, Tuan; Karam, Chafic; Peric, Stojan; Margania, Temur; Murai, Hiroyuki; Bilinska, Malgorzata; Shakarishvili, Roman; Smilowski, Marek; Guglietta, Antonio; Ulrichts, Peter; Vangeneugden, Tony; Utsugisawa, Kimiaki; Verschuuren, Jan; Mantegazza, Renato; De Bleecker, Jan...
Journal:
Lancet neurology
Issue:
Volume 20:Issue 7(2021)
Page Start:
526
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗